Bank Of America Corp Nrx Pharmaceuticals, Inc. Transaction History

Bank Of America Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$0.26 - $0.47 $7,781 - $14,066	-29,928 Reduced 99.76%	72 $0
Q1 2023 May 12, 2023	SELL	$0.66 - $1.4 $3,833 - $8,132	-5,809 Reduced 16.22%	30,000 $19,000
Q4 2022 Feb 10, 2023	BUY	$0.79 - $9.19 $28,031 - $326,088	35,483 Added 10884.36%	35,809 $39,000
Q3 2022 Nov 14, 2022	BUY	$0.2 - $8.07 $1 - $48	6 Added 1.88%	326 $0
Q2 2022 Aug 12, 2022	SELL	$0.51 - $2.42 $595 - $2,824	-1,167 Reduced 78.48%	320 $0
Q1 2022 May 16, 2022	SELL	$2.45 - $5.04 $7,065 - $14,535	-2,884 Reduced 65.98%	1,487 $3,000
Q4 2021 Feb 08, 2022	SELL	$4.5 - $11.91 $67,459 - $178,542	-14,991 Reduced 77.42%	4,371 $21,000
Q3 2021 Nov 15, 2021	BUY	$8.52 - $24.77 $164,964 - $479,596	19,362 New	19,362 $179,000

17.4K

Ticker NRXP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,641,296
Market Cap $81.2M
Description
NRX Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. Its products include ZYESAMI, an investigational drug that has completed a Phase IIb/III clinical study for COVID-19 related respiratory failure; and NRX-10...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.